OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT3 signaling in immunity
Emily J. Hillmer, Huiyuan Zhang, Haiyan S. Li, et al.
Cytokine & Growth Factor Reviews (2016) Vol. 31, pp. 1-15
Open Access | Times Cited: 598

Showing 1-25 of 598 citing articles:

NF-κB, inflammation, immunity and cancer: coming of age
Koji Taniguchi, Michael Karin
Nature reviews. Immunology (2018) Vol. 18, Iss. 5, pp. 309-324
Closed Access | Times Cited: 2185

JAK–STAT pathway targeting for the treatment of inflammatory bowel disease
Azucena Salas, Cristian Hernández-Rocha, Marjolijn Duijvestein, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 6, pp. 323-337
Closed Access | Times Cited: 473

Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Jennifer Huynh, Ashwini L. Chand, Daniel J. Gough, et al.
Nature reviews. Cancer (2018) Vol. 19, Iss. 2, pp. 82-96
Closed Access | Times Cited: 446

The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose‐John, Kevin Winthrop, Leonard H. Calabrese
Nature Reviews Rheumatology (2017) Vol. 13, Iss. 7, pp. 399-409
Closed Access | Times Cited: 379

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj, Moses M. Kasembeli, Prema Robinson, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 2, pp. 486-526
Open Access | Times Cited: 238

Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques
Malika Aïd, Kathleen Busman‐Sahay, Samuel J. Vidal, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1354-1366.e13
Open Access | Times Cited: 215

Salmonella Typhimurium and inflammation: a pathogen-centric affair
Jorge E. Galán
Nature Reviews Microbiology (2021) Vol. 19, Iss. 11, pp. 716-725
Open Access | Times Cited: 213

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
Bei Huang, Xiaoling Lang, Xihong Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 207

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202

Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
Zhuanzhuan Qiang, Hui Dong, Yangyang Xia, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 172

Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review
Alexandre Fabre, Sarah Marchal, Vincent Barlogis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2019) Vol. 7, Iss. 6, pp. 1958-1969.e9
Open Access | Times Cited: 164

Anti-inflammatory effects of Rhodiola rosea L.: A review
Weiling Pu, Mengying Zhang, Ruyu Bai, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109552-109552
Open Access | Times Cited: 164

Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses
Jie Chen, Fengzhe Xu, Xixian Ruan, et al.
EBioMedicine (2023) Vol. 89, pp. 104494-104494
Open Access | Times Cited: 100

Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1263-1321
Closed Access | Times Cited: 59

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
Yang Zhao, Junfeng Du, Xiaofei Shen
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43

Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 41

Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
Yuanfang Li, Baiwei Zhao, Juzheng Peng, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101042-101042
Open Access | Times Cited: 33

Targeting the STAT3/IL-36G signaling pathway can be a promising approach to treat rosacea
Xin Meng, Yun Zhong, Xuyuan Kuang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 33

YY1 Lactylation Aggravates Autoimmune Uveitis by Enhancing Microglial Functions via Inflammatory Genes
Jiaxing Huang, Xiaotang Wang, Na Li, et al.
Advanced Science (2024) Vol. 11, Iss. 19
Open Access | Times Cited: 26

Systems biology dissection of PTSD and MDD across brain regions, cell types, and blood
Nikolaos P. Daskalakis, Artemis Iatrou, Chris Chatzinakos, et al.
Science (2024) Vol. 384, Iss. 6698
Closed Access | Times Cited: 22

Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
Yuhan Wang, Junsha An, Jianbo Zhou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2

STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer
Ayman Oweida, Laurel B. Darragh, Andy V. Phan, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 12, pp. 1339-1349
Open Access | Times Cited: 136

ZNF341 controls STAT3 expression and thereby immunocompetence
Stefanie Frey-Jakobs, Julia Maria Hartberger, Manfred Fliegauf, et al.
Science Immunology (2018) Vol. 3, Iss. 24
Open Access | Times Cited: 133

Novel activators and small-molecule inhibitors of STAT3 in cancer
Lehe Yang, Shichong Lin, Lingyuan Xu, et al.
Cytokine & Growth Factor Reviews (2019) Vol. 49, pp. 10-22
Open Access | Times Cited: 111

The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases
Yu Gao, Honglei Zhao, Peng Wang, et al.
Scandinavian Journal of Immunology (2018) Vol. 88, Iss. 6
Open Access | Times Cited: 107

Page 1 - Next Page

Scroll to top